Continue to improve the level of customs clearance facilitation

Guangzhou Customs Boosts Innovation and Development of Biomedical Industry

The biomedical industry is a strategic emerging industry in Guangzhou and a key area of technological innovation in the Guangdong-Hong Kong-Macao Greater Bay Area. From January to July this year, the import and export of biomedical products in Guangzhou was 15.64 billion yuan, a year-on-year increase of 19.4%, of which exports were 3.47 billion yuan, a year-on-year increase of 28.6%, and imports were 12.17 billion yuan, a year-on-year increase of 17%.

Haizhu Customs officers of Guangzhou Customs are inspecting a batch of imported reagents. Yuan Xiaojun/Photo

Facilitation of customs clearance with "one-time approval, multiple write-offs"

On August 3, Guangzhou Jinyuda Logistics Co., Ltd. applied for the import of a single oligonucleotide pool through the South China Biomaterials Entry and Exit Public Service Platform. The customs clearance procedures were completed within 20 minutes, and it was quickly delivered to the enterprise laboratory.

"This consignment was imported by the enterprise multiple times within a year, and it belongs to the low-risk biological research and development sample of the same product name and specification. The customs provides the convenience of 'one-time approval, multiple write-offs', 'fast approval, and full monitoring'." Haizhu Customs Zhang Zhenya, chief of the Biological Island Supervision Section, introduced.

At present, Guangzhou Customs implements health and quarantine facilities for R&D enterprises that import reagents, samples and other biological R&D samples for their own testing, R&D, technological innovation and other purposes and are used in human medicine, life sciences and other related fields, but not for sale. . If the same R&D enterprise unit imports similar low-risk biological R&D samples, the on-site assessment of biosafety control requirements such as storage conditions and waste disposal is generally not repeated. Improve customs clearance efficiency. The 15 biological research and development enterprises and units in Guangzhou International Biological Island enjoy this convenience.

"One-stop" customs clearance boosts R&D innovation of scientific research enterprises

On the afternoon of August 10, Chen Jie, Chairman and General Manager of Guangzhou Sage Biotechnology Co., Ltd. (hereinafter referred to as "Sage Bio"), came to the Haizhu Customs Biological Island Supervision Point of Guangzhou Customs to share a good news with the customs officers : The enterprise scientific research project "A method and tag adapter for non-invasive virus biopsy based on high-throughput gene sequencing" recently won the 22nd China Patent Award.

In the context of the global epidemic, the biopharmaceutical market continues to have strong demand for research and development. The award-winning scientific research project of Saizhe Biotechnology involves more than 200 pieces of imported raw materials, with a value of more than 30 million yuan, including genetic analyzers, sample processing systems, workstations, kits, etc. These raw materials are time-sensitive and efficient. High value, and often eager to put into research and development. Chen Jie said that many reagents, materials, and testing equipment of enterprises need to be imported, and the convenience measures "tailor-made" by the customs for scientific research enterprises are like boosters, which has added strength to enterprises' R&D innovation.。

"District-Island Linkage" continues to compress customs clearance time

On August 11, Guangzhou International Biological Island celebrated its tenth anniversary. In the past ten years, Bio Island has developed from a Jiangxin Island Village to the core engine of Guangzhou's biopharmaceutical industry. The business development of the South China Biomaterials Entry and Exit Public Service Platform has witnessed the growth and changes of Bio Island. The platform is stationed by Haizhu Customs. Since the trial operation in April 2018, the business volume has grown steadily. The scope of import and export commodities has expanded from 24 items in 10 categories to 75 items in 28 categories. The number of companies that declare on the platform (including integrated declaration) has reached 120 home, an increase of about 4 times.

Guangzhou Customs gives full play to the advantages of island-based supervision, promotes the "region-island linkage" between Baiyun Airport Comprehensive Bonded Zone, Nansha Comprehensive Bonded Zone and Biological Island, and cooperates with drug regulatory authorities to create a green channel for testing to help biopharmaceutical products be quickly distributed out of the area to ensure biological protection. Fast customs clearance of pharmaceutical products. According to the calculation of the company, the application of two fast customs clearance channels for biopharmaceutical goods, such as "Baiyun Airport-Bio Island" and "Guangzhou East Station-Bio Island", has shortened the customs clearance time by 70% compared with the previous time, and reduced the cost of customs declaration, logistics, warehousing, and labor for enterprises. 20%. Data from the South China Biomaterials Entry-Exit Public Service Platform shows that from January to July this year, the total import and export value of pharmaceutical products of Guangzhou International Bio-island enterprises was 396 million yuan, a year-on-year increase of 28%.

Haizhu Customs, a subsidiary of Guangzhou Customs, preached the recent customs clearance facilitation measures to enterprises on Guangzhou International Bio-island

In order to promote the innovation and development of Guangzhou's biopharmaceutical industry, Guangzhou Customs has deepened the reform of "delegating power, delegating power, delegating power and improving services", continuously improving the level of customs clearance facilitation, and realizing "one-stop" import and export customs clearance for biopharmaceutical goods such as biological materials, medicines, medical equipment, and testing equipment. Procedures to meet the needs of biopharmaceutical enterprises, experts and scholars in South China, scientific research institutions and foreign counterparts for joint research and development, production, academic exchanges, inspections, etc., and help accelerate the agglomeration and development of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.

▼Long press the QR code below to get more information on the "Entry and Exit of Biological Materials" service